Company Profile
name | SymBio Pharmaceuticals Limited | |
---|---|---|
English name | SymBio Pharmaceuticals Limited | |
location | Toranomon 30 Mori Building, 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan MAP Representative phone number: 03-5472-1125 FAX number: 03-5472-3054 |
|
Established | March 25, 2005 | |
capital | 17,548,459,551 yen (as of the end of December 2022) | |
Board of Directors | Fuminori Yoshida | Reprentative Director |
Shigetoshi Matsumoto | Board of Directors<Outside> | |
Bruce David Cheson | Board of Directors<Outside> | |
Eiji Ebinuma | Board of Directors<Outside> | |
Kiyoshi Watanabe | Board Director, Full-Time Audit & Supervisory Committee Member<Outside> | |
Kesao Endo | Board Director, Audit & Supervisory Committee Member<Outside> | |
Yasuhiro Tamo | Board Director, Audit & Supervisory Committee Member<Outside> | |
Corporate Officer | Fuminori Yoshida | President and Chief Executive Officer |
Takaaki Fukushima | Executive Corporate Officer, Chief Financial Officer | |
Koji Fukushima | Corporate Officer and Deputy CMO | |
Masahiko Okuno | Corporate Officer | |
Hiroyuki Horita | Corporate Officer | |
Stephane Berthier | Corporate Officer | |
subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA Stephane Berthier CEO and President |